Bayer breaks ground on German cell and gene therapy centre
Once completed, the Berlin site will also be the new home for one of the company’s Bayer Co. Lab start-up incubators.
List view / Grid view
Once completed, the Berlin site will also be the new home for one of the company’s Bayer Co. Lab start-up incubators.
Deal with Kaerus Bioscience for KER-0193 could be worth $450m to the UK-based biotech.
Significant investment in advanced technologies Is expected to support global adoption of mass spectrometry in the next five years.
First-of-its-kind case continues EMA and MHRA harmonisation, streamlining the global biosimilar approval pathway.
The European Commission hopes its planned legislation will enable biotechnology companies to bring products from laboratory to market more quickly.